Literature DB >> 29201446

Surgical treatment of low and intermediate grade lung net.

Mariano García-Yuste1, José María Matilla1, Miguel Angel Cañizares2, Laureano Molins3, Ricardo Guijarro4.   

Abstract

BACKGROUND: Carcinoids now constitute complex tumours which require a multidisciplinary approach and long-term follow-up. Surgical intervention is nowadays confirmed as the mainstay of treatment.
METHODS: From 1980 to 2015, EMETNE-SEPAR collected 1,339 patients treated surgically for bronchial carcinoid (1,154 typical and 185 atypical carcinoids). Standard and conservative procedures were considered with regard to surgical approach. All the patients with carcinoid were pathologically coded following the standards of the 7th edition 2009 TNM lung cancer staging. Statistical analyses were performed in order to determine whether histology, nodal affectation and surgical technique were associated with significant differences in survival, presence of metastases and local recurrence.
RESULTS: The influence of the surgical procedure on overall survival, the presence of metastases and local recurrence were demonstrated as no significant in our sample in central tumours (P>0.05). Sublobar resections in peripheral tumours are related to a decrease in survival in typical carcinoids (P=0.008) with nodal involvement and an increased number of recurrences in atypical carcinoids without nodal involvement (P=0.018).
CONCLUSIONS: In central typical carcinoid, the use of lung-sparing bronchoplastic techniques could influence local recurrence in some cases. This observation demands the intraoperative pathologic verification of an adequate surgical margin by frozen section. Peripheral typical carcinoids have been surgically treated, occasionally, by sublobar resection. However, in peripheral atypical carcinoid after a limited sublobar resection the observed increase of the probability of local recurrence makes it, in our opinion, not advisable.

Entities:  

Keywords:  Typical carcinoid; atypical carcinoid; conservative lung resection; surgical treatment

Year:  2017        PMID: 29201446      PMCID: PMC5690946          DOI: 10.21037/jtd.2017.09.83

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  21 in total

Review 1.  Management of carcinoid tumors.

Authors:  Frank C Detterbeck
Journal:  Ann Thorac Surg       Date:  2010-03       Impact factor: 4.330

2.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

3.  Prognostic model of survival for typical bronchial carcinoid tumours: analysis of 1109 patients on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours Working Group.

Authors:  Pier Luigi Filosso; Francesco Guerrera; Andrea Evangelista; Stefan Welter; Pascal Thomas; Paula Moreno Casado; Erino Angelo Rendina; Federico Venuta; Luca Ampollini; Alessandro Brunelli; Franco Stella; Mario Nosotti; Federico Raveglia; Valentina Larocca; Ottavio Rena; Stefano Margaritora; Francesco Ardissone; William D Travis; Inderpal Sarkaria; Dariusz Sagan
Journal:  Eur J Cardiothorac Surg       Date:  2015-01-05       Impact factor: 4.191

4.  Neuroendocrine bronchial and thymic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  K Öberg; P Hellman; P Ferolla; M Papotti
Journal:  Ann Oncol       Date:  2012-10       Impact factor: 32.976

5.  The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.

Authors:  William D Travis; Elisabeth Brambilla; Andrew G Nicholson; Yasushi Yatabe; John H M Austin; Mary Beth Beasley; Lucian R Chirieac; Sanja Dacic; Edwina Duhig; Douglas B Flieder; Kim Geisinger; Fred R Hirsch; Yuichi Ishikawa; Keith M Kerr; Masayuki Noguchi; Giuseppe Pelosi; Charles A Powell; Ming Sound Tsao; Ignacio Wistuba
Journal:  J Thorac Oncol       Date:  2015-09       Impact factor: 15.609

6.  Is sublobar resection sufficient for carcinoid tumors?

Authors:  Sai Yendamuri; David Gold; Vijay Jayaprakash; Elisabeth Dexter; Chukwumere Nwogu; Todd Demmy
Journal:  Ann Thorac Surg       Date:  2011-06-24       Impact factor: 4.330

7.  Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid.

Authors:  W D Travis; W Rush; D B Flieder; R Falk; M V Fleming; A A Gal; M N Koss
Journal:  Am J Surg Pathol       Date:  1998-08       Impact factor: 6.394

8.  Typical and atypical carcinoid tumours: 20-year experience with 89 patients.

Authors:  F Davini; A Gonfiotti; C Comin; A Caldarella; F Mannini; A Janni
Journal:  J Cardiovasc Surg (Torino)       Date:  2008-10-24       Impact factor: 1.888

9.  Bronchial carcinoid tumors: nodal status and long-term survival after resection.

Authors:  Giuseppe Cardillo; Francesco Sera; Marco Di Martino; Paolo Graziano; Roberto Giunti; Luigi Carbone; Francesco Facciolo; Massimo Martelli
Journal:  Ann Thorac Surg       Date:  2004-05       Impact factor: 4.330

10.  The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer.

Authors:  Valerie W Rusch; Hisao Asamura; Hirokazu Watanabe; Dorothy J Giroux; Ramon Rami-Porta; Peter Goldstraw
Journal:  J Thorac Oncol       Date:  2009-05       Impact factor: 15.609

View more
  4 in total

1.  Prognostic significance of histopathological factors in survival and recurrence of atypical carcinoid tumours.

Authors:  Eva-María García-Fontán; Miguel-Ángel Cañizares-Carretero; Montserrat Blanco-Ramos; Jose-María Matilla-González; Rommel Carrasco-Rodríguez; Francisco Barreiro-Morandeira; Mariano García-Yuste
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-05-27

2.  Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices.

Authors:  Natasha Rekhtman; Patrice Desmeules; Anna M Litvak; Maria C Pietanza; Maria Lauren Santos-Zabala; Ai Ni; Joseph Montecalvo; Jason C Chang; Amanda Beras; Isabel R Preeshagul; Joshua K Sabari; Charles M Rudin; Marc Ladanyi; David S Klimstra; William D Travis; Wei-Chu Lai
Journal:  Mod Pathol       Date:  2019-03-28       Impact factor: 7.842

Review 3.  Orthopedia Homeobox (OTP) in Pulmonary Neuroendocrine Tumors: The Diagnostic Value and Possible Molecular Interactions.

Authors:  Laura Moonen; Jules Derks; Anne-Marie Dingemans; Ernst-Jan Speel
Journal:  Cancers (Basel)       Date:  2019-10-08       Impact factor: 6.639

4.  Construction and validation of nomograms based on the log odds of positive lymph nodes to predict the prognosis of lung neuroendocrine tumors.

Authors:  Suyu Wang; Juan Wei; Yibin Guo; Qiumeng Xu; Xin Lv; Yue Yu; Meiyun Liu
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.